Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

More articles from 5.1 Airway Pharmacology and Treatment

  • Pharmacokinetics, safety and tolerability of CHF5993 a triple pMDI in renal impaired patients
    Fabrizia Mariotti, Sara Collarini, Stefano Vezzoli, Daniela Acerbi, Maxim Kots, Piotr Kuna
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4064; DOI: 10.1183/13993003.congress-2016.PA4064
  • Direct cost analysis of COPD patients: A 1 year follow-up study
    Ünal Akel, Süleyman Savas Hacievliyagil, Zeynep Ayfer Aytemur, Saim Yologlu, Saltuk Bugra Kaya, Nazan Akel
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4070; DOI: 10.1183/13993003.congress-2016.PA4070
  • Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
    Wei Erh Cheng, Shan Chieh Wu, Sandy Ian-U. Chong, Jou Ying Chen, Hsiang-Wen Lin
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4061; DOI: 10.1183/13993003.congress-2016.PA4061
  • Clinical characteristics and outcomes of elderly patients with COPD: TIOSPIR® post-hoc analysis
    Daniel Dusser, Peter M.A. Calverley, Robert A. Wise, Achim Mueller, Norbert Metzdorf, Antonio Anzueto
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4083; DOI: 10.1183/13993003.congress-2016.PA4083
  • The effect of aclidinium bromide 400 µg on sleep quality in COPD: A pilot study
    Helgo Magnussen, Michael Arzt, Stefan Andreas, Tanja Plate, Anna Ribera, Beatriz Seoane, Henrik Watz, Anne-Marie Kirsten
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4051; DOI: 10.1183/13993003.congress-2016.PA4051
  • Total and free IgE in evolution of severe asthma after omalizumab treatment
    María del Carmen Vennera, Mariona Pascal, Ebymar Arismendi Nunez, César Picado
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4117; DOI: 10.1183/13993003.congress-2016.PA4117
  • Pharmacological interaction between glycopyrronium bromide and indacaterol fumarate on the human airways tone
    Luigino Calzetta, Paola Rogliani, Ermanno Puxeddu, Josuel Ora, Francesco Facciolo, Maria Gabriella Matera, Mario Cazzola
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4090; DOI: 10.1183/13993003.congress-2016.PA4090
  • Long-acting bronchodilators (LABDs) and major adverse cardiac events (MACE) in patients with COPD: A pooled analysis of 12 randomised trials
    John R. Hurst, Samy Suissa, Klaus F. Rabe, Giovanni Bader, Gerrit Zijlstra, Marcela Gavornikova, Francesco Patalano, Robert Fogel, Konstantinos Kostikas
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4062; DOI: 10.1183/13993003.congress-2016.PA4062
  • SQ HDM SLIT-tablet is effective in patients not well-controlled in GINA treatment steps 2-4
    Johann Christian Virchow, Victoria Cardona, Hanne Villesen, Christian Ljørring, Bente Riis, Frederic de Blay
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4108; DOI: 10.1183/13993003.congress-2016.PA4108
  • Long-acting bronchodilator initiation in COPD and cardio-pulmonary risks: A population-based comparative effectiveness study
    Samy Suissa, Sophie Dell'Aniello, Pierre Ernst
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4084; DOI: 10.1183/13993003.congress-2016.PA4084

Pages

  • Previous
  • Next
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 106

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society